Viewing StudyNCT00338416



Ignite Creation Date: 2024-05-05 @ 4:52 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00338416
Status: COMPLETED
Last Update Posted: 2011-06-10
First Post: 2006-06-16

Brief Title: An Efficacy and Safety Study of PROCRIT Epoetin Alfa in Cancer Patients Receiving Chemotherapy Every Three Weeks
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Organization Data

Organization: Johnson Johnson Pharmaceutical Research Development LLC
Class: INDUSTRY
Study ID: CR004612
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Ortho Biotech Products LP INDUSTRY